ROSEN, TRUSTED INVESTOR COUNSEL, Encourages Verve Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm - VERV - Verve Therapeutics ( NASDAQ:VERV )
NEW YORK, Aug. 27, 2024 ( GLOBE NEWSWIRE ) -- WHY: Rosen Law Firm, a global investor rights law firm, announces it has filed a class action lawsuit on behalf of purchasers of securities of Verve Therapeutics, Inc. VERV between August 9, 2022 and April 1, 2024, both dates inclusive ( the ...
Ticker |
Sentiment |
Impact |
META
|
Neutral
|
6 %
|
VERV
|
Neutral
|
23 %
|